These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 122526)

  • 21. Species-specific resistance to antimocrobial synergism in Streptococcus faecium and Streptococcus faecalis.
    Moellering RC; Korzeniowski OM; Sande MA; Wennersten CB
    J Infect Dis; 1979 Aug; 140(2):203-8. PubMed ID: 113469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enterococcal endocarditis.
    Wilkowske CJ
    Mayo Clin Proc; 1982 Feb; 57(2):101-5. PubMed ID: 6798333
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Significance of in-vitro penicillin tolerance in experimental enterococcal endocarditis.
    Kim KS; Bayer AS
    J Antimicrob Chemother; 1987 Apr; 19(4):475-85. PubMed ID: 3108228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic treatment of enterococcal endocarditis: in vitro and in vivo studies.
    Serra P; Brandimarte C; Martino P; Carlone S; Giunchi G
    Arch Intern Med; 1977 Nov; 137(11):1562-7. PubMed ID: 921443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R
    Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial therapy of experimental enterococcal endocarditis.
    Hook EW; Roberts RB; Sande MA
    Antimicrob Agents Chemother; 1975 Nov; 8(5):564-70. PubMed ID: 1211911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Daptomycin (LY146032) treatment of experimental enterococcal endocarditis.
    Bush LM; Boscia JA; Kaye D
    Antimicrob Agents Chemother; 1988 Jun; 32(6):877-81. PubMed ID: 2843085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of streptococcal infective endocarditis.
    Wilson WR; Geraci JE
    Am J Med; 1985 Jun; 78(6B):128-37. PubMed ID: 3925771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enterococcal endocarditis: duration and mode of treatment.
    Tompsett R; Berman W
    Trans Am Clin Climatol Assoc; 1978; 89():49-57. PubMed ID: 100924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experimental endocarditis in rabbits. 7. Results of long-term combined therapy of Streptococcus faecalis endocarditis with penicillin and gentamicin.
    Gutschik E
    Acta Pathol Microbiol Immunol Scand B; 1982 Aug; 90(4):295-302. PubMed ID: 6814183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endocarditis due to streptomycin-susceptible Enterococcus faecalis with high-level gentamicin resistance.
    Spiegel CA; Huycke M
    Arch Intern Med; 1989 Aug; 149(8):1873-5. PubMed ID: 2504123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis.
    Fernandez-Guerrero M; Rouse MS; Henry NK; Geraci JE; Wilson WR
    Antimicrob Agents Chemother; 1987 Mar; 31(3):430-3. PubMed ID: 3579260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endocarditis Caused by Highly Penicillin-Resistant Viridans Group Streptococci: Still Room for Vancomycin-Based Regimens.
    Pericàs JM; Nathavitharana R; Garcia-de-la-Mària C; Falces C; Ambrosioni J; Almela M; García-González J; Quintana E; Marco F; Moreno A; Bayer AS; Miró JM; Karchmer AW;
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penicillin therapy of experimental endocarditis induced by tolerant Streptococcus sanguis and nontolerant Streptococcus mitis.
    Lowy FD; Neuhaus EG; Chang DS; Steigbigel NH
    Antimicrob Agents Chemother; 1983 Jan; 23(1):67-73. PubMed ID: 6830210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis.
    Ingerman M; Pitsakis PG; Rosenberg A; Hessen MT; Abrutyn E; Murray BE; Levison ME
    J Infect Dis; 1987 Jun; 155(6):1226-32. PubMed ID: 3106510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of penicillin tolerance in vivo: prevention of experimental Streptococcus sanguis endocarditis.
    Hess J; Dankert J; Durack D
    J Antimicrob Chemother; 1983 Jun; 11(6):555-64. PubMed ID: 6885680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cephalosporin-aminoglycoside synergism in experimental enterococcal endocarditis.
    Weinstein AJ; Lentnek AL
    Antimicrob Agents Chemother; 1976 Jun; 9(6):983-7. PubMed ID: 938028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuous intravenous versus intermittent ampicillin therapy of experimental endocarditis caused by aminoglycoside-resistant enterococci.
    Hellinger WC; Rouse MS; Rabadan PM; Henry NK; Steckelberg JM; Wilson WR
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1272-5. PubMed ID: 1416826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-level penicillin resistance among isolates of enterococci. Implications for treatment of enterococcal infections.
    Bush LM; Calmon J; Cherney CL; Wendeler M; Pitsakis P; Poupard J; Levison ME; Johnson CC
    Ann Intern Med; 1989 Apr; 110(7):515-20. PubMed ID: 2923386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis.
    Francioli PB; Glauser MP
    Antimicrob Agents Chemother; 1993 Feb; 37(2):207-12. PubMed ID: 8452350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.